Fig. 1: Estimated 5-year mortality odds ratio (OR) by co-existing DM in patients with BC. Points represent adjusted ORs and lines indicate 95% confidence interval (CI).

A ORs are assessed by G-computation (GC), inverse probability of treatment weighting (IPTW), targeted maximum likelihood estimation (TMLE) and TMLE with super-learner (TMLE-SL), respectively. B Sensitivity analysis was conducted by excluding subjects with stage III. C Sensitivity analysis was performed by excluding subjects with age > =70. All ORs are adjusted for baseline age, BMI, Ki67, stage, HER2, ER, PR, lymphatic metastasis, hypertension, and menopause status.